Sepsis grave secundaria a bacteriemia por Chryseobacterium indologenes. Primer caso reportado en México
Resumen
Reportamos el primer caso de infección por Chryseobacterium indologenes en México, un microorganismo oportunista en pacientes inmunodeprimidos.
Caso clínico: hombre de 59 años de edad con diagnóstico de linfoma no Hodking, postrasplantado de médula ósea, hospitalizado durante 21 días, quien manifestó respuesta inflamatoria sistémica. El hemocultivo reportó C. indologenes, con adecuada respuesta clínica al tratamiento con levofloxacina.
Conclusiones: C. indologenes es un microorganismo emergente en las áreas hospitalarias, que afecta predominantemente a pacientes inmunodeprimidos, con estancia prolongada y tratamiento con antibióticos a largo plazo.
Palabras clave: Chyseobacterium indologenes, sepsis grave, bactiremia.
Abstract
Introduction: We report the first isolated case in Mexico of infection by Chryseobacterium indologenes, an emerging pathogen in immunocompromised patients.
Case presentation: The examined case was a 59-year-old male who had been diagnosed with non-Hodgkin lymphoma, had received a bone marrow transplant, and had been hospitalized for 21 days. This patient presented with evidence of a systemic inflammatory response, and C. indologenes was identified in his blood culture. He exhibited an adequate clinical response to treatment with levofloxacin.
Conclusions: C. indologenes is an emerging pathogen in hospital contexts; this pathogen predominantly affects immunocompromised patients who experience prolonged hospital stays and receive extended antibiotic therapy.
Keywords: Chryseobacterium indologenes, severe sepsis, bacteremia.
Sin comentarios